Clinical Trial Update: Pre-operative Immunotherapy Combination Strategies in Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study of pre-operative immunotherapy combination strategies in breast cancer, including estrogen receptor-positive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: Queen Mary University of London | Conditions: Breast Cancer, Estrogen Receptor-positive Breast Cancer | Phase 2 | Status: COMPLETED